Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer and Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05363605
What this trial is testing

[225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more
Fusion Pharmaceuticals Inc. 6
Not applicableStudy completedNCT06307470
What this trial is testing

Nurse-led Mind-body Intervention on Sexual Health for Breast Cancer Survivors

Who this might be right for
Women's Health: Neoplasm of BreastMenopause, PrematureBody Image+2 more
University of Arkansas 43
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT02187783
What this trial is testing

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

Who this might be right for
Tumors With CDK4/6 Pathway Activation
Novartis Pharmaceuticals 106
Not applicableStudy completedNCT00582322
What this trial is testing

Genetic Studies in Breast Cancer

Who this might be right for
Breast CancerOvarian Cancer
Memorial Sloan Kettering Cancer Center 483
Early research (Phase 1)Ended earlyNCT03294694
What this trial is testing

Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer

Who this might be right for
Metastatic Hormone-Receptor-Positive (HR+) Breast CancerHER2-Negative Breast CancerMetastatic Epithelial Ovarian Cancer
Dana-Farber Cancer Institute 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT02644369
What this trial is testing

Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Squamous Cell Cancer of Head and NeckTriple Negative Breast CancerEpithelial Ovarian Cancer+2 more
University Health Network, Toronto 100
Not applicableStudy completedNCT00335491
What this trial is testing

Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+6 more
University of Utah 49
Early research (Phase 1)Looking for participantsNCT03604315
What this trial is testing

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Who this might be right for
Breast CarcinomaFallopian Tube CarcinomaOvarian Carcinoma+5 more
M.D. Anderson Cancer Center 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT02890082
What this trial is testing

Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Institut Cancerologie de l'Ouest 102
Early research (Phase 1)Study completedNCT03790423
What this trial is testing

18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer

Who this might be right for
Breast CancerLung CancerPancreatic Cancer+2 more
Rigshospitalet, Denmark 10
Not applicableStudy completedNCT01601548
What this trial is testing

Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+1 more
Masonic Cancer Center, University of Minnesota 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013
What this trial is testing

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Who this might be right for
Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more
Cancer Research UK 81
Testing effectiveness (Phase 2)Ended earlyNCT02042885
What this trial is testing

A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer

Who this might be right for
Prostate CancerSalivary Gland CancerEndometrial Cancer+3 more
Otsuka Novel Products GmbH 79
Large-scale testing (Phase 3)UnknownNCT03137368
What this trial is testing

Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）

Who this might be right for
CYP2D6 Polymorphism
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Early research (Phase 1)Study completedNCT00034281
What this trial is testing

Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2

Who this might be right for
Breast NeoplasmPancreatic NeoplasmLung Neoplasm+2 more
Takeda 16
Not applicableStudy completedNCT02087592
What this trial is testing

Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Who this might be right for
Hereditary Breast and Ovarian Cancer
Technical University of Munich 69
Early research (Phase 1)Study completedNCT02009631
What this trial is testing

Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors

Who this might be right for
Breast CancerOvarian CancerColon Cancer+3 more
AbbVie 45
Testing effectiveness (Phase 2)Looking for participantsNCT06695845
What this trial is testing

Zanidatamab in Patients With HER2-expressing Tumors

Who this might be right for
Breast CancerGastric CancerEsophageal Cancer+9 more
Jazz Pharmaceuticals 200
Next Page